Avis Budget Group enters its May 20 earnings with one of the most dramatic short-interest unwinds of the year — yet the stock has still halved in a month, leaving shorts and bulls both nursing losses.
Short interest tells the core story here. At 14.6% of the free float on May 12, it remains elevated — but the move in the past month has been one of the fastest unwinds on record for this name. From a peak near 27% of the float in late April, shorts have covered aggressively. The position is down 43% in shares over 30 days and fell another 9.4% just this week. The proximate cause is visible in the institutional data: Pentwater Capital Management, a 10% owner, liquidated the bulk of its position on April 23, booking sales across multiple tranches at prices between $250 and $290 — well above where the stock now trades at $150.54. Pentwater still shows 2.59 million shares held as of April 30, down from a larger stake, so the overhang has not fully cleared.
The lending market has loosened sharply in step with the short-interest decline. Availability has improved from completely exhausted — the borrow pool was fully tapped through most of April — to roughly 26% now. Cost to borrow has collapsed from a mid-April peak above 8.5% to 1.8%, the lowest level in six weeks. That is still a premium to a generic large-cap, but the squeeze conditions that defined April have materially eased. Options positioning has also rotated: the put/call ratio is running at 1.48, well below its 20-day average of 1.92 and back near the 52-week low of 0.88. After April's extreme defensive hedging — PCR touched 2.85 on April 23, the highest of the past year — options traders have dramatically reduced put pressure. The signal is clear: the panic that drove April's borrow squeeze is unwinding.
The Street has been busy recalibrating. After JP Morgan downgraded to Underweight on April 23 — and simultaneously raised its target to $165 from $123, an unusual combination that captured the stock's spike — it reversed course on May 1 and cut to $140. Barclays ran a parallel trajectory: upgrade to Underweight from Equal-Weight on April 20 with a $150 target, then down to $140 on May 5. Jefferies downgraded to Hold on May 1, raising its target to $160 from $112 — another sign that the Street is anchoring to a higher range post-spike, even as consensus has turned negative. Susquehanna raised its Neutral target to $140 from $105 last week. The consensus price target of $127 is now roughly 16% below the current price at $150.54, with the dominant bias being Underweight or Neutral. That is an unusual configuration: the stock has already fallen 50% in a month yet the Street consensus points to further downside.
Valuation supports that cautious read. The P/E multiple has compressed sharply — down 53 points over 30 days to 26.3x — but the EV/EBITDA of 35.6x on the snapshot's standalone basis looks rich against the fundamentals data, which pegs the forward EV/EBITDA closer to 11x. The divergence likely reflects balance-sheet complexity in a business with heavy fleet financing: net debt above $4.9 billion and annual interest expense of roughly $423 million leave thin margin for error. The ORTEX short score of 68.5 ranks the stock in just the 6th percentile for short positioning across the universe — extreme by any measure — even after this week's partial cover.
The earnings history adds further context. The last confirmed result, reported May 1, sent the stock down 6.9% on the day and 19.3% over the following five days. The Q1 report announced April 29 fell just 0.7% on the day but gave back nearly 10% over the next week. The pattern is consistent: this stock reacts badly to prints over any multi-day window. The May 20 earnings date is the clearest near-term marker to watch, particularly given the gap between where analysts are anchoring targets — clustered around $140 — and where the stock trades today.
See the live data behind this article on ORTEX.
Open CAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
